Work

Phase I/II Study of Lenalidomide Combined with DA-EPOCH and Rituximab (DA-EPOCH-R2) in Primary Effusion Lymphoma in Patients with or without HIV

Year: 2019

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2019-122070

Authors: Kathryn Lurain, Ramya Ramaswami, Anaida Widell, Irene Ekwede, Jomy George, Maryalice Stetler-Stevenson, Mark Raffeld, Constance M. Yuan, Joseph Ziegelbauer, Frank Maldarelli, William D. Figg, Cody Peer, Seth M. Steinberg, Denise Whitby, Thomas S. Uldrick, Robert Yarchoan

Institutions: National Cancer Institute, National Institutes of Health, National Institutes of Health Clinical Center, National Institute of Allergy and Infectious Diseases, Center for Cancer Research, Frederick National Laboratory for Cancer Research, Fred Hutch Cancer Center

Language: English

Topic: Viral-associated cancers and disorders

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2986616554

Cites:

Cited by: 8

Related to: 10